HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,547,004 | -10.9% | 151,228 | -15.3% | 0.01% | 0.0% |
| Q2 2023 | $15,207,536 | +76.0% | 178,618 | +71.0% | 0.01% | +66.7% |
| Q1 2023 | $8,641,417 | -24.6% | 104,428 | -28.3% | 0.01% | -33.3% |
| Q4 2022 | $11,458,990 | +58.6% | 145,696 | +49.3% | 0.01% | +80.0% |
| Q3 2022 | $7,226,000 | -17.1% | 97,595 | -27.0% | 0.01% | -16.7% |
| Q2 2022 | $8,717,000 | +15.8% | 133,726 | +12.3% | 0.01% | +20.0% |
| Q1 2022 | $7,529,000 | +26.9% | 119,102 | +6.5% | 0.01% | +66.7% |
| Q4 2021 | $5,932,000 | -26.2% | 111,831 | -1.8% | 0.00% | -40.0% |
| Q3 2021 | $8,038,000 | +9.4% | 113,870 | +3.3% | 0.01% | +25.0% |
| Q2 2021 | $7,345,000 | +20.0% | 110,214 | +99.9% | 0.00% | 0.0% |
| Q1 2021 | $6,121,000 | +335.3% | 55,138 | +365.7% | 0.00% | +300.0% |
| Q4 2020 | $1,406,000 | +50.5% | 11,839 | +10.6% | 0.00% | 0.0% |
| Q3 2020 | $934,000 | -60.3% | 10,709 | -59.2% | 0.00% | -50.0% |
| Q2 2020 | $2,352,000 | -17.2% | 26,257 | -7.9% | 0.00% | -33.3% |
| Q1 2020 | $2,841,000 | +2.4% | 28,496 | +18.0% | 0.00% | +50.0% |
| Q4 2019 | $2,774,000 | +447.1% | 24,141 | +500.7% | 0.00% | – |
| Q3 2019 | $507,000 | +1.8% | 4,019 | -2.9% | 0.00% | – |
| Q2 2019 | $498,000 | -80.9% | 4,141 | -86.1% | 0.00% | -100.0% |
| Q1 2019 | $2,608,000 | +4.3% | 29,825 | +19.3% | 0.00% | 0.0% |
| Q4 2018 | $2,501,000 | +496.9% | 24,998 | +584.5% | 0.00% | – |
| Q3 2018 | $419,000 | +125.3% | 3,652 | +76.3% | 0.00% | – |
| Q2 2018 | $186,000 | -84.7% | 2,071 | -87.6% | 0.00% | -100.0% |
| Q1 2018 | $1,218,000 | -34.2% | 16,643 | -47.8% | 0.00% | 0.0% |
| Q4 2017 | $1,851,000 | -10.4% | 31,873 | -30.7% | 0.00% | -50.0% |
| Q3 2017 | $2,065,000 | -5.5% | 46,024 | -16.9% | 0.00% | 0.0% |
| Q2 2017 | $2,186,000 | +1.4% | 55,371 | +4.2% | 0.00% | 0.0% |
| Q1 2017 | $2,155,000 | -45.8% | 53,129 | -46.3% | 0.00% | -50.0% |
| Q4 2016 | $3,975,000 | +194.0% | 98,881 | +164.8% | 0.00% | +300.0% |
| Q3 2016 | $1,352,000 | +91.5% | 37,335 | +53.4% | 0.00% | 0.0% |
| Q2 2016 | $706,000 | -47.8% | 24,334 | -37.1% | 0.00% | -50.0% |
| Q1 2016 | $1,353,000 | +1473.3% | 38,715 | +1331.2% | 0.00% | – |
| Q4 2015 | $86,000 | -25.9% | 2,705 | -25.1% | 0.00% | – |
| Q3 2015 | $116,000 | -28.8% | 3,610 | -8.2% | 0.00% | – |
| Q2 2015 | $163,000 | -27.6% | 3,934 | -21.5% | 0.00% | – |
| Q1 2015 | $225,000 | +86.0% | 5,009 | +54.2% | 0.00% | – |
| Q4 2014 | $121,000 | -31.6% | 3,248 | -35.9% | 0.00% | – |
| Q3 2014 | $177,000 | +6.0% | 5,064 | +6.9% | 0.00% | – |
| Q2 2014 | $167,000 | +79.6% | 4,736 | +65.9% | 0.00% | – |
| Q1 2014 | $93,000 | -89.1% | 2,854 | -85.9% | 0.00% | -100.0% |
| Q4 2013 | $852,000 | -25.1% | 20,242 | -29.1% | 0.00% | 0.0% |
| Q3 2013 | $1,138,000 | -13.5% | 28,530 | -10.3% | 0.00% | 0.0% |
| Q2 2013 | $1,316,000 | – | 31,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |